The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver

References

• Aebi, H., 1984. Catalase in vitro. Methods in Enzymology, 105, 121–126.
   PubMed Web of Science ®Google Scholar
• Al-Bishri, W.M., 2017. Attenuating impacts of chromium and nano resveratrol against hyperglycemia induced oxidative stress in diabetic rats. International Journal of Pharmaceutical Research & Allied Sciences, 6 (2), 61–69.
   Web of Science ®Google Scholar
• Arınç, E., et al., 1991. Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 dependent drug metabolizing enzymes. Archives of Toxicology, 65 (3), 186–190.
   PubMed Web of Science ®Google Scholar
• Arınç, E., Arslan, Ş., and Adalı, O., 2005. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Archives of Toxicology, 79 (8), 427–433.
   PubMed Web of Science ®Google Scholar
• Arınç, E., et al., 2007. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food and Chemical Toxicology, 45 (1), 107–118.
   PubMed Web of Science ®Google Scholar
• Arınç, E., Yilmaz, D., and Bozcaarmutlu, A., 2015. Mechanism of inhibition of CYP1A1 and glutathione S-transferase activities in fish liver by quercetin, resveratrol, naringenin, hesperidin, and rutin. Nutrition and Cancer, 67 (1), 137–144.
   PubMed Web of Science ®Google Scholar
• Arslan, S., Nuyan, M., and Arınç, E., 2009. Modulatory effects of resveratrol on liver, kidney and lung total GST, GST Mu, NQO1 and CYP2B4, CYP2E1 and CYP3A associated enzyme activities. Drug Metabolism Reviews, 41, 47.
   Web of Science ®Google Scholar
• Atten, M.J., et al., 2001. Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochemical Pharmacology, 62 (10), 1423–1432.
   PubMed Web of Science ®Google Scholar
• Bertelli, A.A. and Das, D.K., 2009. Grapes, wines, resveratrol, and heart health. Journal of Cardiovascular Pharmacology, 54 (6), 468–476.
   PubMed Web of Science ®Google Scholar
• Bozdogan, O., et al., 2013. Effect of ATP-dependent channel modulators on ischemia-induced arrhythmia change depending on age and gender. Experimental Biology and Medicine (Maywood, N.J.), 238 (10), 1170–1179.
   PubMed Web of Science ®Google Scholar
• Bresciani, L., et al., 2014. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. Nutrition, Metabolism, and Cardiovascular Diseases, 24 (4), 408–415.
   PubMed Web of Science ®Google Scholar
• Burke, M.D. and Mayer, R.T., 1974. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metabolism and Disposition , 2 (6), 583–588.
   PubMed Web of Science ®Google Scholar
• Carlberg, I. and Mannervik, B., 1985. Glutathione reductase. Methods in Enzymology, 113, 484–490.
   PubMed Web of Science ®Google Scholar
• Chander, V., et al., 2017. A review on pharmacological potential of berberine; an active component of Himalayan Berberis aristata. The Journal of Phytopharmacology, 6 (1), 53–58.
   Google Scholar
• Chandirasegaran, G., Elanchezhiyan, C., and Ghosh, K., 2018. Effects of berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats. Biomedicine & Pharmacotherapy, 99, 227–236.
   PubMed Web of Science ®Google Scholar
• Chatterjee, P. and Franklin, M.R., 2003. Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metabolism and Disposition, 31 (11), 1391–1397.
   PubMed Web of Science ®Google Scholar
• Chatuphonprasert, W., Lao-Ong, T., and Jarukamjorn, K., 2014. Improvement of superoxide dismutase and catalase in streptozotocin–nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharmaceutical Biology, 52 (4), 419–427.
   Web of Science ®Google Scholar
• Chatuphonprasert, W., et al., 2012. Modulations of cytochrome P450 expression in diabetic mice by berberine. Chemico-Biological Interactions, 196 (1–2), 23–29.
   PubMed Web of Science ®Google Scholar
• Chatuphonprasert, W., et al., 2011. Suppression of beta-naphthoflavone induced CYP1A expression and lipid-peroxidation by berberine. Fitoterapia, 82 (6), 889–895.
   PubMed Web of Science ®Google Scholar
• Cheng, Z., et al., 2006. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochimica et Biophysica Acta, 1760 (11), 1682–1689.
   PubMed Web of Science ®Google Scholar
• Cochin, J. and Axelrod, J., 1959. Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine. The Journal of Pharmacology and Experimental Therapeutics, 125 (2), 105–110.
   PubMed Web of Science ®Google Scholar
• de la Lastra, C.A. and Villegas, I., 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society Transactions, 35 (Pt 5), 1156–1160.
   PubMed Web of Science ®Google Scholar
• Delmas, D., et al., 2011. Transport, stability, and biological activity of resveratrol. Annals of the New York Academy of Sciences, 1215, 48–59.
   PubMed Web of Science ®Google Scholar
• Deng, R., et al., 2014. Resveratrol suppresses the inducible expression of CYP3A4 through the pregnane X receptor. Journal of Pharmacological Sciences, 126 (2), 146–154.
   PubMed Web of Science ®Google Scholar
• Elbe, H., et al., 2015. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Human & Experimental Toxicology, 34 (1), 100–113.
   PubMed Web of Science ®Google Scholar
• El-Mowafy, A.M. and Alkhalaf, M., 2003. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis, 24 (5), 869–873.
   PubMed Web of Science ®Google Scholar
• Favreau, L.V. and Schenkman, J.B., 1988. Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treatment. Diabetes, 37 (5), 577–584.
   PubMed Web of Science ®Google Scholar
• Gallagher, E.P., et al., 1996. Channel catfish glutathione S-transferase isoenzyme activity toward (+/–)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Aquatic Toxicology, 34 (2), 135–150.
   Web of Science ®Google Scholar
• García-Suástegui, W.A., et al., 2017. The role of CYP2E1 in the drug metabolism or bioactivation in the brain. Oxidative Medicine and Cellular Longevity, 2017, 4680732.
   PubMed Web of Science ®Google Scholar
• Gudima, S.O., et al., 1994. Kinetic analysis of interaction of human immunodeficiency virus reverse transcriptase with alkaloids. Molekuliarnaia Biologiia, 28 (6), 1308–1314.
   Web of Science ®Google Scholar
• Habig, W.H., Pabst, M.J., and Jakoby, W.B., 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry, 249 (22), 7130–7139.
   PubMed Web of Science ®Google Scholar
• Halliwell, B., 1995. Antioxidant characterization. Methodology and mechanism. Biochemical Pharmacology, 49 (10), 1341–1348.
   PubMed Web of Science ®Google Scholar
• Hamadi, N., et al., 2012. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. Journal of Biochemical and Molecular Toxicology, 26 (10), 384–392.
   PubMed Web of Science ®Google Scholar
• Hodek, P., Trefil, P., and Stiborová, M., 2002. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chemico-Biological Interactions, 139 (1), 1–21.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Ito, A., and Sato, R., 1966. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry, 60 (4), 417–428.
   PubMed Web of Science ®Google Scholar
• Ioannides, C. and Lewis, D.F., 2004. Cytochromes P450 in the bioactivation of chemicals. Current Topics in Medicinal Chemistry, 4 (16), 1767–1788.
   PubMed Web of Science ®Google Scholar
• Kaur, G., et al., 2016. Garlic and resveratrol attenuate diabetic complications, loss of beta-cells, pancreatic and hepatic oxidative stress in streptozotocin-induced diabetic rats. Frontiers in Pharmacology, 7, 360.
   PubMed Web of Science ®Google Scholar
• Kaya, S.T., et al., 2019. The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial KATP channel. Archives of Physiology and Biochemistry, 125 (2), 114–121.
   PubMed Web of Science ®Google Scholar
• Kettmann, V., et al., 2004. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Die Pharmazie, 59 (7), 548–551.
   PubMed Web of Science ®Google Scholar
• Kim, T.S., et al., 2003. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology, 109 (3), 407–414.
   PubMed Web of Science ®Google Scholar
• Kim, S.O. and Kim, H.J., 2013. Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. Journal of Medicinal Food, 16 (6), 511–517.
   PubMed Web of Science ®Google Scholar
• Kirchheiner, J., et al., 2005. Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. Clinical Pharmacokinetics, 44 (12), 1209–1225.
   PubMed Web of Science ®Google Scholar
• Kong, W., et al., 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 10 (12), 1344–1351.
   PubMed Web of Science ®Google Scholar
• Küpeli, E., et al., 2002. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sciences, 72 (6), 645–657.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry, 193 (1), 265–275.
   PubMed Web of Science ®Google Scholar
• Ma, Q. and Lu, A.Y., 2007. CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metabolism and Disposition , 35 (7), 1009–1016.
   PubMed Web of Science ®Google Scholar
• Martínez-Gómez, C., et al., 2006. Monitoring biomarkers in fish (Lepidorhombus boscii and Callionymus lyra) from the northern Iberian shelf after the Prestige oil spill. Marine Pollution Bulletin, 53 (5–7), 305–314.
   PubMed Web of Science ®Google Scholar
• Moutsatsou, P., 2007. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens, Greece), 6 (3), 173–193.
   PubMedGoogle Scholar
• Naritomi, Y., Terashita, S., and Kagayama, A., 2004. Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Xenobiotica, 34 (5), 415–427.
   PubMed Web of Science ®Google Scholar
• Nash, T., 1953. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. The Biochemical Journal, 55 (3), 416–421.
   PubMed Web of Science ®Google Scholar
• Patel, H., et al., 2013. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovascular Diabetology, 12, 142.
   PubMed Web of Science ®Google Scholar
• Piconi, L., Quagliaro, L., and Ceriello, A., 2003. Oxidative stress in diabetes. Clinical Chemistry and Laboratory Medicine, 41 (9), 1144–1149.
   PubMed Web of Science ®Google Scholar
• Piver, B., et al., 2004. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochemical Pharmacology, 68 (4), 773–782.
   PubMed Web of Science ®Google Scholar
• Racková , L., et al., 2004. Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects. Bioorganic & Medicinal Chemistry, 12 (17), 4709–4715.
   PubMed Web of Science ®Google Scholar
• Rahman, T., et al., 2012. Oxidative stress and human health. Advances in Bioscience and Biotechnology, 3 (7), 997–1019.
   Google Scholar
• Rajasekaran, S., Sivagnanam, K., and Subramanian, S., 2005. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacological Reports, 57 (1), 90–96.
   PubMed Web of Science ®Google Scholar
• Raza, H., et al., 2000. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. Journal of Biochemical and Molecular Toxicology, 14 (3), 131–139.
   PubMed Web of Science ®Google Scholar
• Raza, H., et al., 2004. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes, 53 (1), 185–194.
   PubMed Web of Science ®Google Scholar
• Sadi, G., Bozan, D., and Yildiz, H.B., 2014. Redox regulation of antioxidant enzymes: post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver. Molecular and Cellular Biochemistry, 393 (1–2), 111–122.
   PubMed Web of Science ®Google Scholar
• Sapmaz, C., et al., 2020. Modulation of xenobiotic metabolizing enzyme activities in rat liver by co-administration of morin, endosulfan, and 7,12-dimethylbenz[a]anthracene. Drug and Chemical Toxicology, 43 (1), 13–21.
   PubMed Web of Science ®Google Scholar
• Schmatz, R., et al., 2012. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie, 94 (2), 374–383.
   PubMed Web of Science ®Google Scholar
• Szkudelska, K. and Szkudelski, T., 2010. Resveratrol, obesity and diabetes. European Journal of Pharmacology, 635 (1–3), 1–8.
   PubMed Web of Science ®Google Scholar
• Tang, L.Q., et al., 2006. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. Journal of Ethnopharmacology, 108 (1), 109–115.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., et al., 2013. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Current Pharmaceutical Design, 19 (34), 6064–6093.
   PubMed Web of Science ®Google Scholar
• Tran, Q.L., et al., 2003. In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. Journal of Ethnopharmacology, 86 (2–3), 249–252.
   PubMed Web of Science ®Google Scholar
• van Herwaarden, A.E., et al., 2007. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. The Journal of Clinical Investigation, 117 (11), 3583–3592.
   PubMed Web of Science ®Google Scholar
• Vollekova, A., et al., 2003. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytotherapy Research, 17 (7), 834–837.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2003. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. British Journal of Clinical Pharmacology, 55 (1), 77–85.
   PubMed Web of Science ®Google Scholar
• Wu, B. and Dong, D., 2012. Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends in Pharmacological Sciences, 33 (12), 656–668.
   PubMed Web of Science ®Google Scholar
• Zhao, X., et al., 2008. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats. Biomedicine & Pharmacotherapy,62 (9), 567–572.
   PubMed Web of Science ®Google Scholar
• Zharikova, O.L., et al., 2009. Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochemical Pharmacology, 78 (12), 1483–1490.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2010. Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharmaceutics & Drug Disposition, 31 (4), 228–242.
   PubMed Web of Science ®Google Scholar